瑞斯康集團(01679.HK)延遲刊發2019年經審核年度業績公告
格隆匯4月16日丨瑞斯康集團(01679.HK)公佈,由於自2020年年初起中國爆發冠狀病毒(COVID-19)疫情,截至2019年12月31日止年度的年度業績審核程序不可避免地延遲,且不能按計劃完成,主要原因是北京實行出行及交通限制,並對旅客採取檢疫措施,阻礙到核數師於實地進行若干審核程序。
隨着跡象顯示中國疫情逐步穩定,預計北京將進一步解除出行及交通限制以及檢疫措施,讓核數師得以進行實地審核工作。視乎北京解除出行及交通限制以及檢疫措施的實際時間,預計截至2019年12月31日止年度的經審核年度業績將取得核數師同意,並於2020年5月8日或之前刊發,而公司將於2020年5月14日(星期四)或之前刊發及寄發截至2019年12月31日止年度的年報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.